![]() |
![]() | ![]() |
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. |
Product Pipeline of Life Medical Sciences includes: (Based on a research report by Hancock Institutional Equity Services) * Cariel for Wound Healing * Piliel for Hair Regrowth * Repel for Preventing Surgical Adhesions * Scar Management Device * Sure-Closure(TM) Device About a year ago, I saw a picture by CHAI showing hair color changing from gray to black. I also saw a research report by Wedbush Morgan Security, giving a 12 month target of $20. The stock, however, only made to $11 in January, and is now under $7. This summer, the Hancock research report again give $20 as 12 month goal. Anyone know more about the potential of this company? | ||||||||||||||
|
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
| © 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |